India's Bal Pharma climbs on receipt of EU GMP certification
05/04/2019 07:36
** Shares of Bal Pharma Ltd BALP.NS rose as much as 10.76
pct to 76.7 rupees, their highest since February 25, 2019
** The formulations manufacturing unit of the company at
Uttarakhand received good manufacturing practice (GMP)
compliance certification according to European Union
regulations, the company said on Thursday urn:newsml:reuters.com:*:nFWN21M07V
** The approval allowed the plant to manufacture finished
formulations for supplying to regulated markets of Europe, U.S.,
Japan and Australia among others, the company added.
** Stock was on track for its second consecutive session of
gains
** Up to Thursday's close, stock had fallen 12.45 pct so far
this year
((Reuters Messaging:
chandini.m.thomsonreuters.com@reuters.net))